BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19205713)

  • 1. Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy.
    Doi D; Boh Y; Konishi H; Asakura H; Takeshita T
    Arch Gynecol Obstet; 2009 Oct; 280(4):633-6. PubMed ID: 19205713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer.
    Méndez LE; Mueller A; Salom E; González-Quintero VH
    Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1200-2. PubMed ID: 14607056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.
    Sood AK; Shahin MS; Sorosky JI
    Gynecol Oncol; 2001 Dec; 83(3):599-600. PubMed ID: 11733979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete response of a stage IV mucinous cystadenocarcinoma of the ovary to systemic chemotherapy employing paclitaxel and carboplatin.
    Yokoyama Y; Kaji H; Kondoh H; Takeuchi E; Yamasaki Y; Inui Y
    Gynecol Obstet Invest; 2001; 52(3):210-4. PubMed ID: 11598367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer.
    Vapattanawong P
    J Med Assoc Thai; 2006 Sep; 89(9):1357-61. PubMed ID: 17100369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma.
    Hubalek M; Smekal-Schindelwig C; Zeimet AG; Sergi C; Brezinka C; Mueller-Holzner E; Marth C
    Arch Gynecol Obstet; 2007 Aug; 276(2):179-83. PubMed ID: 17342499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review.
    Mantovani G; Gramignano G; Mais V; Melis GB; Parodo G; Carrucciu GM
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):238-9. PubMed ID: 16698170
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical generalized granuloma annulare associated with two visceral cancers.
    Shimizu S; Yasui C; Tsuchiya K
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S236-8. PubMed ID: 16631952
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: a case report.
    Huang HP; Fang CN; Kan YY
    Eur J Gynaecol Oncol; 2004; 25(5):635-6. PubMed ID: 15493185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
    Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T
    Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP; Manahan KJ; Wiemann MC
    Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary.
    Henderson CE; Elia G; Garfinkel D; Poirier MC; Shamkhani H; Runowicz CD
    Gynecol Oncol; 1993 Apr; 49(1):92-4. PubMed ID: 8482567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma.
    Malfetano JH; Goldkrand JW
    Obstet Gynecol; 1990 Mar; 75(3 Pt 2):545-7. PubMed ID: 2304734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF; Liu FY; Chen FJ; Feng YL
    Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the treatment of ovarian carcinoma].
    Pfisterer J; du Bois A; Hilpert F; Wagner U; Meier W
    Dtsch Med Wochenschr; 2004 Feb; 129(8):379-84. PubMed ID: 14961446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ovarian cancer and pregnancy].
    Ayoubi J; Elghaoui A; Ko Kivok-Yun P; Fournie A; Monrozies X; Reme JM
    Rev Fr Gynecol Obstet; 1995; 90(7-9):335-41. PubMed ID: 7481437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review.
    Picone O; Lhommé C; Tournaire M; Pautier P; Camatte S; Vacher-Lavenue MC; Castaigne D; Morice P
    Gynecol Oncol; 2004 Aug; 94(2):600-4. PubMed ID: 15297214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 51Cr-EDTA clearance to tailor a carboplatin therapeutic regimen in ovarian cancer patients.
    Martino G; Frusciante V; Varraso A; Barbano F; Capotorto A; Dicembrino F; Petruzzelli F; Rubini G
    Anticancer Res; 1999; 19(6C):5587-91. PubMed ID: 10697623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience.
    Thigpen T; Vance RB; McGuire WP; Hoskins WJ; Brady M
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):23-31. PubMed ID: 8553080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.